by Claya Editorial Team | Jan 4, 2025 | Drug comparisons, GLP-1 and Medical Science
When you’re exploring weight loss medications, two names tend to come up often: phentermine and semaglutide. Phentermine has been around for decades, offering a quick and convenient way to suppress appetite and jumpstart weight loss. But semaglutide, a newer...
by Claya Editorial Team | Dec 20, 2024 | Drug comparisons, GLP-1 and Medical Science
If you’re exploring medication options for weight loss, you’ve probably seen two names pop up repeatedly: phentermine and tirzepatide. Phentermine has been around for decades, and is widely prescribed as an appetite suppressant. Tirzepatide, on the other hand, is a...
by Claya Editorial Team | Dec 14, 2024 | GLP-1 and Medical Science
You’ve probably heard a lot about semaglutide lately. It’s become one of the most talked-about medications for weight loss, thanks to brands like Ozempic and Wegovy. If you’re thinking about trying semaglutide for weight loss, you might have some questions about what...
by Claya Editorial Team | Dec 12, 2024 | GLP-1 and Medical Science
If you’re considering medical weight loss and GLP-1 medications, you’ve probably come across two options: compounded semaglutide and Ozempic. But what, exactly, is the difference, and why might you choose one over the other? Let’s break it down so you know exactly...
by Claya Editorial Team | Dec 10, 2024 | GLP-1 and Medical Science
For decades, obesity treatment has been a long, exhausting battle. And yet despite all the effort, most people have ended up with the same frustrating results — weight lost, then regained. Why? Because traditional obesity treatment never addressed the real culprit —...
by Claya Editorial Team | Dec 8, 2024 | Drug comparisons, GLP-1 and Medical Science
If you’re managing type 2 diabetes or looking into weight loss treatments, you’ve probably come across two names: semaglutide and Ozempic. But are they actually different? The short answer: not really. Let’s get to the bottom of what sets them apart—and how they’re...
